Epidemiological profile of the disease of the new coronavirus in the interior of Mato Grosso
DOI:
https://doi.org/10.21527/2176-7114.2022.46.11844Keywords:
COVID-19, Epidemiological profile, Public Health Surveillance, Infection from coronavirus, Health careAbstract
Objective: to analyze the epidemiological profile of the disease of the new coronavirus in the municipality of Pontal do Araguaia, Mato Grosso. Method: descriptive and retrospective epidemiological study, using secondary data for the period from April 17 to October 23, 2020. Results: in the of interval epidemiological weeks 288 cases were confirmed, of which 52.4% were women, aged between 30 and 39 years (24.7%). 92.36% of the patients had symptoms, predominantly coughing (51%), comorbidities were associated in only 8%, most of whom had diabetes mellitus and hospitalization occurred in 10% of cases. Regarding deaths, most were women with an average age of 74 years. The municipality had a recovery rate of 96.18% and 2.4% lethality. Conclusion: primary health care has been able to sustain the necessary care to control the transmission of the new coronavirus in the municipality studied.
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506.
World Health Organization. Coronavirus disease (COVID-19). Reference: situation report – 51 [Internet]. 2020 [citado 2020 out 27]. Disponível em: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10.
World Health Organization. Coronavirus (COVID-19) dashboard [Internet]. 2020 [citado 2022 jul 25]. Disponível em: Disponível em: https://covid19.who.int/.
Rodriguez-Morales AJ, Gallego V, Escalera-Antezana JP, Méndez CA, Zambrano LI, Franco-Paredes C, et.al. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Med Infect Dis. 2020 May-Jun;35:101613.
Ministério da Saúde (BR). Portaria nº 454, 20 de março de 2020. Declara em todo território nacional, o estado de transmissão comunitária do coronavírus (covid-19) [Internet]. 2020 [citado 2022 jul 26]. Disponível: https://www.planalto.gov.br/ccivil_03/portaria/prt454-20-ms.htm
Ministério da Saúde (BR). Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde [Internet]. 2022 [citado 2022 jul 25]. Disponível: https://covid.saude.gov.br/.
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Doença pelo Novo Coronavírus - COVID-19. Boletim Epidemiológico Especial 118. Semana Epidemiológica 24 (12/06 a 18/06/22) [Internet]. 2022 [citado 2022 jul 25].
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Guia de Vigilância Epidemiológica Emergência de Saúde Pública de Importância Nacional pela Doença pelo Coronavírus 2019 Vigilância de Síndromes Respiratórias Agudas COVID-19. Brasília, DF: Editora MS; 2020.
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020;382(12):1177-1179.
Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, Ma K. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021 Feb;54(1):12-16.
Lovato A, de Filippis C, Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19). Am J Otolaryngol. 2020;41(3):102474.
Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020;323(18):1775-1776.
Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020;43(6):867-869.
Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049-6057.
Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523.
Vital Strategies, World Health Organization. Revealing the Toll of COVID-19: A Technical Package for Rapid Mortality Surveillance and Epidemic Response [Internet]. Nova York: Vital Strategies; 2020. [citado 2022 jul 29].
Ministério da Saúde (BR). Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Diretrizes para diagnóstico e tratamento da COVID-19. Brasília, DF: Editora MS; 2020.
Instituto Brasileiro de Geografia e Estatística (IBGE). Censo demográfico 2010 [Internet]. Rio de Janeiro: IBGE; [citado 2020 out 28]. Disponível em: https://www.ibge.gov.br/cidades-e-estados/mt/pontal-do-araguaia.html.
Secretaria Municipal de Saúde. Pontal do Araguaia. Atualização 109. Situação epidemiológica COVID-19. 23/10/2020 [Internet]. 2020 [citado 2022 jul 25]. Disponível em: https://www.pontaldoaraguaia.mt.gov.br/site/wp-content/uploads/2020/10/Boletim-109-2020-10-23.pdf.
Secretaria de Estado de Mato Grosso (MT). Painel Epidemiológico nº 229 Coronavírus/COVID-19 Mato Grosso. 23/10/2020 [Internet]. 2020 [citado 2022 jul 25].
Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29.
Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588(7837):315-320.
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Nature. 2020;584(7821):430-436.
Klokner SGM, Luz RAd, Araujo, PHdM, Knapik J, Sales, et al. Perfil epidemiológico e preditores de fatores de risco para a COVID-19 na região sul do Brasil. Research, Society and Development. 2021;10(3):1-13.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25.
Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020; 8(9):782-792.
Lovato A, de Filippis C, Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19). Am J Otolaryngol. 2020;41(3):102474.
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Diretrizes para diagnóstico e tratamento da COVID-19. Brasília, DF: Editora MS; 2020.
Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J MedVirol. 2020 Sep;92(9):1.518-1.524.
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-151.
Kanne JP, Chest CT. Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist. Radiology. 2020;295(1):16-17.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Contexto & Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.
